<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Our suggested approach to titrating systemic unfractionated heparin infusion in neonates based upon anti-Xa levels and aPTT</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Our suggested approach to titrating systemic unfractionated heparin infusion in neonates based upon anti-Xa levels and aPTT</h1>
<div class="graphic"><div class="figure"><div class="ttl">Our suggested approach to titrating systemic unfractionated heparin infusion in neonates based upon anti-Xa levels and aPTT</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm summarizes our suggested approach to monitoring and adjusting UFH in neonates receiving UFH for therapeutic anticoagulation. Though UFH is not the preferred first-line agent for neonates requiring therapeutic anticoagulation, it may be used in select circumstances such as patients with renal failure or those with bleeding risks who require finely tuned titration and the ability to quickly turn on or off the infusion (eg, patients requiring multiple surgeries or other invasive procedures). Prior to initiating UFH treatment, all neonates should have pretreatment testing performed, including CBC with platelet count, coagulation studies (PT/INR, aPTT, and fibrinogen level), and head ultrasound. Patients with significant thrombocytopenia or evidence of coagulopathy prior to treatment (eg, prolonged PT or aPTT) should undergo evaluation for the cause; UFH therapy may need to be deferred until the coagulopathy is treated or resolved. During UFH therapy, we suggest monitoring both the aPTT and anti-Xa levels to guide dose adjustments. Refer to the UpToDate topic on neonatal thrombosis for additional details.</div><div class="graphic_footnotes">aPTT: activated partial thromboplastin time; 
	UFH: unfractionated heparin; 
	ULN: upper limit of normal; 
	CBC: complete blood count; 
	PT: Pprothrombin time; 
	INR: international normalized ratio; 
	DIC: disseminated intravascular coagulation.<br/>

	* If the anti-Xa level is persistently low despite multiple dose adjustments, some experts would measure the neonate's antithrombin level and supplement if low.<br/>
	
	¶ If the anti-Xa level is persistently high despite multiple dose adjustments, the neonate's renal function should be evaluated. In addition, heparin contamination of the blood sample should be excluded.<br/>
	
	Δ The ULN for aPTT is higher in neonates compared with older children and adults. However, not all laboratories reflect this in their reference ranges for aPTT and neonates may be incorrectly flagged as having a high baseline aPTT. In such circumstances, the aPTT on heparin therapy should be interpretted relative to the baseline (pretreatment) aPTT rather than the ULN of the reference range.<br/>
<span class="lozenge">◊</span> Dose adjustments for the UFH infusion according to anti-Xa levels are as follows:
    <ul>
<li>Anti Xa ≤0.1 – Give bolus of 50 units/kg, then increase maintenance infusion by 10%; the bolus dose should be withheld or reduced if there are significant bleeding risks (eg, extremely low birth weight, septicemia)</li>
<li>Anti Xa 0.11 to 0.34 – Increase maintenance infusion by 10%</li>
<li>Anti Xa 0.35 to 0.7 – No change</li>
<li>Anti Xa 0.71 to 0.99 – Decrease maintenance infusion by 10%</li>
<li>Anti Xa 1.0 to 1.19 – Hold infusion for 30 minutes, then restart at a dose reduced by 10%</li>
<li>Anti Xa ≥1.2 – Hold infusion for 60 minutes, then restart at a dose reduced by 15%</li></ul>
	
	§ Low PTT values despite therapeutic or supratherapeutic anti-Xa levels may be seen if the factor VIII level is elevated. Factor VIII levels can be elevated during active thrombosis, and baseline factor VIII levels are higher in neonates compared with older children and adults. Thus, if the patient has discordant aPTT and anti-Xa levels in this manner, checking the factor VIII level can help explain why the aPTT is low despite therapeutic or supratherapeutic anti-Xa levels. The finding of an elevated factor VIII level confirms that the anti-Xa level is the more reliable measure of anticoagulant activity. In such cases, the clinician should rely on the anti-Xa level rather than the aPTT for subseuent dose titration. No additional intervention is needed to specifically address the elevated factor VIII level.<br/>
	
	¥ If there is a disconnect between the 2 values such that the anti-Xa level is subtherapeutic yet the aPTT is &gt;1.5 × ULN, the UFH dose should not be increased to achieve the desired therapeutic anti-Xa level, since there are reports of serious bleeding occurring in this setting, particularly in neonates. Consultation with a pediatric hematologist is advised.<br/>
	
	‡ A common cause of prolonged aPTT is heparin contamination in the blood sample. If this has been excluded, other causes include DIC, liver disease, and vitamin K deficiency.</div><div class="graphic_reference">References:
<ol>
<li>Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141:e737S.</li>
<li>Trucco M, Lehmann CU, Mollenkopf N, et al. Retrospective cohort study comparing activated partial thromboplastin time versus anti-factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics. J Thromb Haemost 2015; 13:788.</li>
<li>Bhatt MD, Paes BA, Chan AK. How to use unfractionated heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis 2016; 27:605.</li>
</ol></div><div id="graphicVersion">Graphic 134270 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
